Skip to main content Skip to main navigation menu Skip to site footer
Review
Published: 03-06-2022

Nutroterapia na porfiria aguda intermitente: Da UTI ao ambulatório

Departamento de Clínica Médica, Fundação Hospitalar de São Simão, São Simão, GO, Brasil
acute intermittent porphyria nutrition

Abstract

Acute intermittent porphyria is a rare genetic disease, autosomal dominant, with variable penetrance, which causes error in the heme metabolism pathway of the liver, with accumulation of intermediate metabolites that are toxic to the body. It is manifested by crisis with multisystem symptoms, and diagnosis is often difficult. The main findings are severe abdominal pain, polyneuropathy, autonomic dysfunction, and neuropsychiatric disorders. It ranges from mild to very severe with malignant arrhythmia and bulbar paralysis with respiratory failure requiring mechanical ventilation and admission to the intensive care unit. The diagnosis is confirmed biochemistry and genetics. Treatment of the crisis is done away from precipitating factors and specifically with a diet rich in carbohydrates and hematin, with positive effect on the heme biosynthetic pathway. Within the multidisciplinary team, it must be highlighted the role of the nutrition specialist doctor, who evaluates and guides the nutrition therapy, both in crises and in the clinical monitoring of these patients.

Metrics

Metrics Loading ...

References

  1. Thadani H, Deacon A, Peters T. Diagnosis and management of porphyria. BMJ 2000; 320 (7250): 1647-1651
  2. Cojocaru IM, Sapira V, Socoliuc G. , et al. Acute intermittent porphyria--diagnostic and treatment traps. Rom J Intern Med 2012; 50 (01) 33-41
  3. Arandia MC, Aparicio FMO. Porfiria Aguda Intermitente - La Importancia de Ampliar la Perspectiva del Diagnóstico Diferencial. Rev. Cient. Cienc. Med. 2012; 15 (02) 45-48
  4. Schwambach FW. , et al. Porfiria Aguda: O Que Precisamos Saber. Rev. Med. UFPR 2014; 1 (01) 15-20
  5. Dos Santos AR, De Albuquerque RR, Doriqui MJ, Costa GC, Dos Santos AP. Biochemical and hematological analysis in acute intermittent porphyria (AIP): a case report. An Acad Bras Cienc 2013; 85 (03) 1207-1214
  6. Indika NLR, Kesavan T, Dilanthi HW. , et al. Many pitfalls in diagnosis of acute intermittent porphyria: a case report. BMC Res Notes 2018; 11 (01) 552
  7. Gázquez Sisteré I, Luján Mavila K, Chordá Ribelles J, Touzón López C. [Acute intermittent porphyria: a diagnostic dilemma]. Gastroenterol Hepatol 2010; 33 (06) 436-439
  8. Anderson KE, Bloomer JR, Bonkovsky HL. , et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005; 142 (06) 439-450
  9. Zheng X, Liu X, Wang Y. , et al. Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: Two case reports and a literature review. Medicine (Baltimore) 2018; 97 (36) e11665
  10. Morris JH, Bohm NM, Nemecek BD. , et al. Rapidity of correction of hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone following tolvaptan. Am J Kidney Dis 2018; 71 (06) 772-782
  11. Bonkovsky HL, Philip J. Nutritional Advice for Persons with Porphyria. http://www.porphyriafoundation.com/diet-information-for-all-porphyrias. Acessado em 20/03/2019.

How to Cite

Silva Filho, P. V. da. (2022). Nutroterapia na porfiria aguda intermitente: Da UTI ao ambulatório. International Journal of Nutrology, 12(1), 18–22. https://doi.org/10.1055/s-0039-1693736